List of Tables

Table 1. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Restraints

Table 3. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Trends

Table 4. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Industry Policy

Table 5. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity by Company, (2020-2025) & (K L), Ranked Based on Sales in 2024

Table 8. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Average Selling Price (ASP) by Company, (2020-2025) & (US$/L)

Table 10. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Mergers & Acquisitions, Expansion Plans

Table 12. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Manufacturers Product Type

Table 13. Head Office and Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Production Site of Key Manufacturer

Table 14. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Capacity of Major Manufacturers and Future Plan

Table 15. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity by Company, (2020-2025) & (K L), Ranked Based on Sales in 2024

Table 18. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Production & Forecast by Region, 2020 VS 2024 VS 2031, (K L)

Table 20. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Production by Region, 2020-2025, (K L)

Table 21. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Production Forecast by Region, 2026-2031, (K L)

Table 22. Global Key Players of Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Upstream (Raw Materials)

Table 23. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Typical Customers

Table 24. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Typical Distributors

Table 25. by Type, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, 2020-2031, (K L)

Table 30. By Country, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, 2020-2031, (K L)

Table 34. By Country, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2020-2031

Table 35. Abbott Company Information, Head Office, Market Area, and Industry Position

Table 36. Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 37. Abbott Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 38. Abbott Company Profile and Main Business

Table 39. Abbott Recent Developments

Table 40. Amgen Company Information, Head Office, Market Area, and Industry Position

Table 41. Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 42. Amgen Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 43. Amgen Company Profile and Main Business

Table 44. Amgen Recent Developments

Table 45. Arven Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 46. Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 47. Arven Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 48. Arven Pharmaceuticals Company Profile and Main Business

Table 49. Arven Pharmaceuticals Recent Developments

Table 50. Biocon Company Information, Head Office, Market Area, and Industry Position

Table 51. Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 52. Biocon Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 53. Biocon Company Profile and Main Business

Table 54. Biocon Recent Developments

Table 55. Cadila Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 56. Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 57. Cadila Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 58. Cadila Pharmaceuticals Company Profile and Main Business

Table 59. Cadila Pharmaceuticals Recent Developments

Table 60. Dr.Reddy's Laboratories Company Information, Head Office, Market Area, and Industry Position

Table 61. Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 62. Dr.Reddy's Laboratories Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 63. Dr.Reddy's Laboratories Company Profile and Main Business

Table 64. Dr.Reddy's Laboratories Recent Developments

Table 65. Emcure Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 66. Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 67. Emcure Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 68. Emcure Pharmaceuticals Company Profile and Main Business

Table 69. Emcure Pharmaceuticals Recent Developments

Table 70. Intas Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position

Table 71. Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 72. Intas Pharmaceuticals Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 73. Intas Pharmaceuticals Company Profile and Main Business

Table 74. Intas Pharmaceuticals Recent Developments

Table 75. Kyowa Kirin Company Information, Head Office, Market Area, and Industry Position

Table 76. Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 77. Kyowa Kirin Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 78. Kyowa Kirin Company Profile and Main Business

Table 79. Kyowa Kirin Recent Developments

Table 80. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 81. Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 82. Novartis Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 83. Novartis Company Profile and Main Business

Table 84. Novartis Recent Developments

Table 85. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 86. Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 87. Pfizer Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 88. Pfizer Company Profile and Main Business

Table 89. Pfizer Recent Developments

Table 90. Reliance Life Sciences Company Information, Head Office, Market Area, and Industry Position

Table 91. Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 92. Reliance Life Sciences Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 93. Reliance Life Sciences Company Profile and Main Business

Table 94. Reliance Life Sciences Recent Developments

Table 95. Harbin Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 96. Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 97. Harbin Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 98. Harbin Pharmaceutical Company Profile and Main Business

Table 99. Harbin Pharmaceutical Recent Developments

Table 100. North China Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 101. North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 102. North China Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 103. North China Pharmaceutical Company Profile and Main Business

Table 104. North China Pharmaceutical Recent Developments

Table 105. Jiuyuan Gene Company Information, Head Office, Market Area, and Industry Position

Table 106. Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 107. Jiuyuan Gene Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 108. Jiuyuan Gene Company Profile and Main Business

Table 109. Jiuyuan Gene Recent Developments

Table 110. Kexing Biopharm Company Information, Head Office, Market Area, and Industry Position

Table 111. Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 112. Kexing Biopharm Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 113. Kexing Biopharm Company Profile and Main Business

Table 114. Kexing Biopharm Recent Developments

Table 115. Qilu Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 116. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 117. Qilu Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 118. Qilu Pharmaceutical Company Profile and Main Business

Table 119. Qilu Pharmaceutical Recent Developments

Table 120. Quangang Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 121. Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 122. Quangang Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 123. Quangang Pharmaceutical Company Profile and Main Business

Table 124. Quangang Pharmaceutical Recent Developments

Table 125. Sunway Biotech Company Information, Head Office, Market Area, and Industry Position

Table 126. Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 127. Sunway Biotech Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 128. Sunway Biotech Company Profile and Main Business

Table 129. Sunway Biotech Recent Developments

Table 130. SL Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 131. SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 132. SL Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 133. SL Pharmaceutical Company Profile and Main Business

Table 134. SL Pharmaceutical Recent Developments

Table 135. Four Rings Bio-Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 136. Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 137. Four Rings Bio-Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 138. Four Rings Bio-Pharmaceutical Company Profile and Main Business

Table 139. Four Rings Bio-Pharmaceutical Recent Developments

Table 140. Amoytop Company Information, Head Office, Market Area, and Industry Position

Table 141. Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 142. Amoytop Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 143. Amoytop Company Profile and Main Business

Table 144. Amoytop Recent Developments

Table 145. Wuzhong Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 146. Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Models, Specifications, and Application

Table 147. Wuzhong Pharmaceutical Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L), Revenue (US$ Million), Price (US$/L) and Gross Margin, 2020-2025

Table 148. Wuzhong Pharmaceutical Company Profile and Main Business

Table 149. Wuzhong Pharmaceutical Recent Developments

List of Figures

Figure 1. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Picture

Figure 2. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, (K L) & (2020-2031)

Figure 4. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Average Selling Price (ASP), (2020-2031) & (US$/L)

Figure 5. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity (K L) & (2020-2031)

Figure 7. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Average Selling Price (ASP), (US$/L) & (2020-2031)

Figure 8. By Consumption Value, China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Share of Global, 2020-2031

Figure 10. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Key Participants, Market Share, 2024

Figure 12. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Production Market Share & Forecast by Region, 2020-2031

Figure 15. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Industry Chain

Figure 16. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Procurement Model

Figure 17. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Model

Figure 18. Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Channels, Direct Sales, and Distribution

Figure 19. Vials

Figure 20. Prefilled

Figure 21. by Type, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value, 2020-2031, US$ Million

Figure 22. by Type, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value Market Share, 2020-2031

Figure 23. by Type, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, 2020-2031, (K L)

Figure 24. by Type, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2020-2031

Figure 25. by Type, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Average Selling Price (ASP), 2020-2031, (US$/L)

Figure 26. Myelosuppressive Chemotherapy

Figure 27. Leukemia Chemotherapy

Figure 28. Others

Figure 29. by Application, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value, 2020-2031, US$ Million

Figure 30. by Application, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Revenue Market Share, 2020-2031

Figure 31. by Application, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, 2020-2031, (K L)

Figure 32. by Application, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2020-2031

Figure 33. by Application, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Price, 2020-2031, (US$/L)

Figure 34. By Region, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value Market Share, 2020-2031

Figure 35. By Region, Global Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2020-2031

Figure 36. North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 37. By Country, North America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value Market Share, 2024

Figure 38. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 39. By Country, Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value Market Share, 2024

Figure 40. Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 41. By Country/Region, Asia Pacific Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value Market Share, 2024

Figure 42. South America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 43. By Country, South America Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value Market Share, 2024

Figure 44. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 45. United States Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, 2020-2031, (K L)

Figure 46. by Type, United States Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 47. by Application, United States Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 48. Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, 2020-2031, (K L)

Figure 49. by Type, Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 50. by Application, Europe Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 51. China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, 2020-2031, (K L)

Figure 52. by Type, China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 53. by Application, China Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 54. Japan Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, 2020-2031, (K L)

Figure 55. by Type, Japan Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 56. by Application, Japan Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 57. South Korea Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, 2020-2031, (K L)

Figure 58. by Type, South Korea Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 59. by Application, South Korea Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 60. Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, 2020-2031, (K L)

Figure 61. by Type, Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 62. by Application, Southeast Asia Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 63. India Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, 2020-2031, (K L)

Figure 64. by Type, India Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 65. by Application, India Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 66. Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity, 2020-2031, (K L)

Figure 67. by Type, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 68. by Application, Middle East & Africa Recombinant Human Granulocyte Colony-Stimulating Factor Injection (rhG-CSF) Sales Quantity Market Share, 2024 VS 2031

Figure 69. Research Methodology

Figure 70. Breakdown of Primary Interviews

Figure 71. Bottom-up Approaches

Figure 72. Top-down Approaches